Biogen Inc.’s Alzheimer’s drug will be of little help to the company’s third-quarter sales, Wall Street analysts said, as the drugmaker faces an uphill task of convincing hospitals and clinics to use the $56,000-a-year treatment and insurers to reimburse Aduhelm.

Facing thousands of lawsuits related to Johnson & Johnson’s talc-based products, the life sciences giant is launching a separate subsidiary dubbed LTL Management LLC that will take the brunt of potential legal liabilities.

Four leading pharmaceutical companies partnered with Amazon Web Services and Israel Biotech Fund to launch AION Labs, an innovative space that will allow drug developers to harness artificial intelligence technologies and computational science to solve therapeutic challenges.

The Ashfield Excellence Academy was formed to design, develop and deliver specialist training, skills assessments and process consultancy to the healthcare and pharma industries.

AREA 23 (an IPG Health company) launched the multi-platform campaign “Lil Sugar” in collaboration with global non-profit organization Hip Hop Public Health to raise awareness about the hidden sugars in many foods.

With $19 million in seed funding led by the Retinal Degeneration Fund, Opus Genetics launched with a mission to develop gene therapies for rare forms of blindness driven by genetic mutations.

McCann Health New Jersey is launching a new campaign for Evofem Biosciences Inc.’s revolutionary hormone-free birth control product, Phexxi. Starring Emmy® Award winning actress Annie Murphy, the cheeky and flirty campaign “House Rules” was led by an all-female creative, strategy and account team.

Dr. Reddy’s Laboratories Ltd. along with the company’s subsidiaries announced that Reddy-Lenalidomide, a generic equivalent to Revlimid (lenalidomide) capsules, was approved by Health Canada and launched in the Canadian market.

Shoreline Biosciences is developing an off-the-shelf, targeted, allogeneic approach to natural killer (NK) and macrophage cell therapies which the immunotherapy company’s chairman and CEO believes is one-of-a-kind.

Med Ad News talked to the management team of LevLane about the process of building best brands, key factors in producing a successful brand launch, navigating the launch of new products and campaigns with clients during the COVID-19 pandemic, and other topics.